0000919574-23-006304.txt : 20231114 0000919574-23-006304.hdr.sgml : 20231114 20231114103427 ACCESSION NUMBER: 0000919574-23-006304 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 EFFECTIVENESS DATE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAXTON CORP CENTRAL INDEX KEY: 0001388551 IRS NUMBER: 222437619 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15293 FILM NUMBER: 231402507 BUSINESS ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-419-1800 MAIL ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false true false 0001388551 XXXXXXXX 09-30-2023 09-30-2023 false CAXTON CORP
731 Alexander Road Building 2, Suite 500 Princeton NJ 08540
13F HOLDINGS REPORT 028-15293 N
Heath Weisberg Chief Compliance Officer 212-205-6805 /s/ Heath Weisberg Princeton NJ 11-14-2023 0 9 26321829 true
INFORMATION TABLE 2 infotable.xml ACLARIS THERAPEUTICS INC COM 00461U105 133387 19473 SH SOLE 19473 0 0 ALLAKOS INC COM 01671P100 111978 49329 SH SOLE 49329 0 0 APOGEE THERAPEUTICS INC COM 03770N101 265653 12472 SH SOLE 12472 0 0 COMPASS THERAPEUTICS INC COM 20454B104 170942 86773 SH SOLE 86773 0 0 ELEVATION ONCOLOGY INC COM 28623U101 14453 21813 SH SOLE 21813 0 0 MOLECULAR TEMPLATES INC COM NEW 608550208 864993 136866 SH SOLE 136866 0 0 REZOLUTE INC COM NEW 76200L309 1741036 1318967 SH SOLE 1318967 0 0 SAVARA INC COM 805111101 12525416 3313602 SH SOLE 3313602 0 0 XERIS BIOPHARMA HOLDINGS INC COM 98422E103 10493971 5641920 SH SOLE 5641920 0 0